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Introduction
The cancer of the large bowel and rectum accounts for 10% of 
cancers in men and for 11% of cancers in women. It was the 
second most-common site-specific cancer in Europe in 2006 
(Ferlay et al 2007) affecting both men and women (after the 
breast cancer), with an increasing incidence. One study from 
western region of Romania revealed that the prevalence of colo-
rectal cancer is relatively high (Fratila et al 2010). In men pros-
tatic cancer was on the first place and lung cancer on the second 
place; in women the first and second places were for breast can-
cer and colorectal cancer, the third being for endometrial cancer. 
It is considered that the frequency of the disease increases with 
age, reaching a maximum around the age of 75 years. A lot of 
environmental and genetic factors were implicated in the epi-
demiology of colorectal cancer. Sporadic cancers are frequently 
diagnosed than the cases in which we know genetic predisposi-
tion for colorectal cancer. More than 50% of the malignant tu-
mours arise in the large bowel. Polyps, benign tumours of the 
large bowel are found in 25% of the cases. A percent of 4-6% of 
the patients are diagnosed with synchronous cancers (Fante et 
al 1996; Hohenberger 2000). Lynch syndrome (hereditary non-
polyposis colorectal cancer) is characterized by mutations that 
occurs in the DNA mismatch-repair genes. Until now we have 
information concerning five genes: MSH2 (mutS homolog 2) 
on chromosome 2p16; MLH1 (mutL homolog 1) on chromo-
some 3p21; MSH6 (mutS homolog 6) on chromosome 2p16; 
PMS2 (postmeiotic segregation 2) on chromosome 7p22; and 
EPCAM or TACSTD1 gene, which is responsible for a small 
percentage of HNPCC cases, it’s deletion mutations inactivate 
MSH2 (Kovacs et al 2009; Ligtenberg et al 2009). The affected 
members of the family tend to develop colon cancers, usually 
in the right colon, earlier than usually, in their 30’s to 40’s, be-
ing also at elevated risk for developing cancer at different sites: 
genital, gastric, ureter, bile ducts, brain and skin.
Hereditary colon cancer syndromes are caused by specific in-
herited mutations that can lead to colon polyps, colon cancers, 
and non-colonic cancers. Hereditary colon cancer syndrome is 
able affect multiple members of a family. It is considered that 
5% of all colon cancers are due to hereditary colon cancer syn-
dromes. Patients who have inherited one of these syndromes 
have an extremely high risk (90-100%) for developing colon 
cancer. The risk to develop a colon cancer is 6% if one first de-
gree relative has history of colon cancer; and if there is a sec-
ond cancer, the risk rises up to 17%.
For the development of colon cancer there are four different se-
quential mutations found: the APC gene (adenomatous polyposis 
coli), K-ras, DCC (deleted in colon cancer) and p53 gene. The 
APC gene is a tumour suppression gene, located on chromo-
some 5, having an autosomal dominant transmission for FAP. 
The p53 protein has multiple functions, among them there are: 
regulation of the cell growth, the repair of DNA, inhibiting the 
cell growth meanwhile the repair of DNA and the apoptosis. The 
MYH syndrome is an autosomal recessive form of colorectal 
adenomatous polyposis, in which the patients develop 10-100 
polyps during their 40’s and they are at high risk to degenerate 
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into colon cancer. The responsible gene is MutY Homologue 
located on the position 1p34.4-p32.1.
Synchronous cancers of colorectum are considered to be those 
diagnosed preoperatively, intraoperatively or in no more than 
6 months period postoperatively. These tumours  have to be 
separate by at least 4 cm distance one from another, without 
submucosal spread or a satellite lesion of each other (Cunliffe 
et al 1984). In case of not respecting these criteria the tumours 
are considered as regional spread or metastatic lesions.
Material and methods
We made a retrospective study of 20 cases which underwent 
surgical procedures for multiple synchronous tumours of the 
large bowel and rectum, in a period of 7.5 years, represent-
ing 4.76% of all colorectal cancers diagnosed and treated in 
our hospital. In the same time there were more than 400 cases 
of colo-rectal cancers. The diagnosis was made on clinical ex-
amination, abdominal ultrasound, colonoscopy, barium enema 
and laparotomy. Only six patients underwent also a CT scan. 
Usually for the patients without occlusive colorectal cancer the 
golden standard is colonoscopy. Whenever it is present an oc-
clusive tumour, the preparation of the bowel cannot be done, 
and also even a colonoscope cannot pass through the stenosis, 
that is why there still are cases in which the synchronous malig-
nant tumours are not diagnosed preoperatively. Some of them 
may be diagnosed with a proper intraoperatory exploration of 
the peritoneal cavity and some of them may be diagnosed after 
surgery with a new colonoscopy or with another occlusive ab-
dominal tumour. 18 patients underwent surgical procedures, one 
has colonic biopsies and diagnosis but never came for surgical 
treatment and in one it was initiated a chemotherapy protocol 
because of advance disease.
Results
The association of the synchronous malignant tumours  were: 
ascendent colon and right colon angle in two, cecum and right 
colon flexure in two, sigmoid colon and transverse colon in two, 
recto-sigmoid junction and rectum in three, upper and lower rec-
tum in one, recto-colic malignant polyposis with multiple colon 
cancers in two, recto-sigmoid junction and descendant colon in 
one, left colon angle and sigmoid in one, sigmoid colon in one, 
right colon angle and descendant colon in one, transverse colon 
and recto-sigmoidal junction in one, cecum and ascendant co-
lon in one, cecum and descendant colon in one, right colon an-
gle and left colon angle in one. The 2 patients with recto-colic 
malignant poliposis were not included in a familial syndrome. 
The surgical operations performed in time for these patients 
were: total colectomy in 3, segmentary resections in 4, enlarged 
left hemicolectomy in 3, right hemicolectomy in 6, Hartmann 
procedure in one, abdomino-perineal rectal resection in 3, ileo-
sigmoidostomy in one, transversostomy in 2 and no operation 
in 2 (one patient underwent chemotherapy because of distant 
metastases and one is lost in follow-up).
There were 13 males and 7 females, with a median age of 67 
(range 38-81). The cancers sites were as in Fig.2. We divided 
the large bowel and rectum in 9 sites: cecum, the ascendant 
colon, the hepatic flexure of the colon, the transverse colon, 
the left flexure of the colon, the descendant colon, the sigmoid 
colon, the sigmoidal-rectal junction and the rectum. If we would 
divide the large bowel and the rectum just in two places, the 
right and the left colon, we would have a small preponderance 
of the malignant tumours  located on the left side.
Figure 1. The anatomical sections of the large intestine
There were 13 males and 7 females, with a median age of 67 
(range 38-81). The cancers sites were as in Fig.2. We divided 
the large bowel and rectum in 9 sites: cecum, the ascendant 
colon, the hepatic flexure of the colon, the transverse colon, 
the left flexure of the colon, the descendant colon, the sigmoid 
colon, the sigmoidal-rectal junction and the rectum. If we would 
divide the large bowel and the rectum just in two places, the 
right and the left colon, we would have a small preponderance 
of the malignant tumours  located on the left side.
There were 53 tumours most of them on left side of the bowel. 
An interesting case was that of the patient B.I., diagnosed with 4 
large bowel cancers (villous and tubulo-villous adenocarcinoma) 
2 cancers on the sigmoid colon, one on the descendant colon 
and one on the transverse colon, for which was performed a 
left hemicolectomy with transverso-rectoanastomosis; one year 
later at a colonoscopic control were found 2 additional cancers 
(tubulo-vilous adenocarcinoma), one on the transverse colon 
and the other on the cecum, for which it was performed a right 
hemicolectomy and also a rectal resection, so it was completed 
a total rectocolectomy with ileo-anal mechanical anastomosis.
Another patient, R.M. diagnosed after a colonoscopy with a 
recto-sigmoidal malignant tumour with stenosis for which was 
performed a recto-sigmoidectomy with anastomosis, developed 
after 4 weeks a cecal diastatic perforation for which was 
performed a cecostomy. Chirilă et al 2012
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The perforation appeared because of an occlusive tumor of the 
transverse colon, for which it was performed 6 weeks later a 
segmentary transverse colon resection with transverse colostomy, 
closed later. This was a typical case of an incomplete diagnosis 
before surgery and in time of surgery. 
This happened because of intestinal occlusion at presentation 
and a big malignant recto-sigmoidal tumour which did not allow 
the passage of the endoscope through the tumour and in time of 
surgical intervention was not performed a careful investigation 
of the entire colon. The patient is well, 4 years after surgery.
In 2 patients was performed a total colectomy with a J pouch 
ileo-rectal anastomosis because of multiple tumours, benign 
(polyps) and malignant.
The surgical treatment for the synchronous colorectal cancers were 
segmentary resections with restoration of the bowel continuity 
usually end-to-end, most of them performed manually and in 
one patient mechanically, in 2 cases at the level of the transverse 
colon and other 2 on the sigmoid colon; right (6 patients) or left 
(3 patients) hemicolectomies; total colectomy with ileo-rectal 
anastomosis in one patient, with ileal J-pouch in 2 patients 
(Chirilă et al 2012); internal by-pass (side-to-side ileo-sigmoidal 
anastomosis) in one patient; Hartmann resections in 2 patients; 
external palliative derivation in 2 patient and in one patient a 
loop sigmoidostomy after a recto-sigmoidal resection in order 
to protect the anastomosis. Other surgical procedures done 
with colorectal procedures were: bilateral adnexectomy in one 
patient, cholecystectomy in one patient, partial cystectomy in one 
patient, abdominal wall hernia repair in one patient, adherential 
syndrome lisis in 4 patients. Some of the patients had secondary 
neoplasms, especially liver metastases (6 patients), pulmonary 
metastases (2 patients), or other sites (peritoneal carcinomatosis 
in 2 patients). The postoperatively complications were: fistula 
in 2 patients, recovered with medical treatment; an evisceration 
with second suture of the abdominal wall in one patient; and 
wound infection in 3 patients. One patient died within 30 days 
postoperatively because of a stroke. Associated diseases were 
described in many patients. The most frequent was ischaemic 
heart disease and hypertension in 6 patients, diabetes mellitus 
in 6 patients, dislipidemia in 2 patients, in two patients it was 
diagnosed an alteration of the glucose metabolism, liver cirrhosis 
in 2 patients, renal chronic failure in 2 patients, bronchial asthma 
in one patient. The histopathological examination revealed tubullar, 
tubullar-vilous, tubullo-papillar adenocarcinoma, most of them 
with mild differenciation and some of them poor differentiated. 
Figure 2. The localisation of colorectal malignant tumours, either synchronous or metachronous for the 20 patients; in the figure 
are represented also the synchronous benign colorectal tumours (polyps)Chirilă et al 2012
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In the patients with colorectal polyposis were diagnosed also 
tubullar adenomas, tubullo-villous adenomas with displazia. The 
patients with colorectal malignant tumours had stage I of disease 
in 1 patient, stage IIA of disease in 4 patients, stage IIIB in 5 
patients, IIIC in one patient and stage IV in 8 patients. One patient 
did not come for surgical treatment, even if she was diagnosed 
with synchronous malignant tumours of the right flexure of the 
colon and the descendant colon (tubullar adenocarcinoma). The 
multiple colorectal malignant tumours  were staged according 
to TNM staging from the American Joint Committee on Cancer 
(AJCC 2002). The stage was considered the most advanced stage 
of the tumours, even if there were 6 different stages malignant 
tumours. Nowadays are still alive only 14 patients, even if some 
of them are diagnosed with metastases, the most common site 
being the liver; one patient with liver cirrhosis. 
Discussions
Colorectal cancer was the fourth most common cancer in men 
and the third most common cancer in women worldwide (Parkin 
et al 2005), even if both incidence and death rates declined not 
only for colorectal cancer but also for lung cancer, prostate 
cancer and breast cancer (Jemal et al 2008). In 2008 colorectal 
cancer occupied the third place in men and the second in women 
(Jemal et al 2011). Usually, men have the incidence and mortality 
rates higher than females. The highest incidence rates were 
found in 2008 in Australia and New Zealand, Europe, and North 
America, and the lowest rates were found in Africa and South-
Central Asia (Ferlay et al 2010). Colorectal cancer incidence 
rates have increased in some areas previously considered at low 
risk, among them Spain and some countries within Eastern Asia 
and Eastern Europe (Center et al 2009a). This could have an 
explanation in changes in dietary patterns, obesity, an increased 
prevalence of smoking and maybe other factors or combination 
of them. In the United States was obtained, through an early 
detection and removal of the premalignant colorectal lesions 
because of cancer screening, a decrease in the incidence rates 
for both sexes (Center et al 2009b).
Billroth has described for the first time in 1879 a case with 
multiple malignant tumours  in a patient (Billroth 1889, cited 
by Varty et al 1994). 
The incidence of multiple primary cancers diagnosed in the 
colon and rectum is observed between 2 to 5% (Takeuchi et al 
1997; Chen and Sheen-Chen, 2000; Ueno et al 2003; Wang et 
al 2004; Tziris et al 2008). This incidence increases to 10-20% 
in patients with familiar adenomatous polyposis, hereditary 
non-polyposis, colorectal cancer, and ulcerative colitis (Yoon 
et al 2008). The synchronous colorectal benign neoplasms are 
frequently reported. The reported incidence of synchronous 
colorectal carcinoma ranged between 1.7 and 12.4% (Ekelund 
and Pihl 1974; Welch, 1981; Cunliffe et al 1984; Eu et al 1993; 
Hennekinne-Mucci et al 2006; Piñol et al 2004).
In the period of time studied by us we had more than 500 cases 
of colorectal malignant tumours, admitted and most of them 
underwent surgery. There were only 5 cases of metachronous 
colorectal lesions. Also, in our series, three patients developed 
metachronous malignant tumours and some of them were 
synchronously discovered. The survival for patients with 
synchronous colon cancers was observed to be similar as for 
patients with solitary colon tumours, considering the highest 
stage synchronous tumor (Passman et al 1996).
The diagnosis of colorectal malignancies in case of bowel 
obstruction with incomplete colonoscopy may be obtained 
with CT colonography, a method with a good quality of images 
and significant accuracy, being very well tolerated and it is lee 
invasive Neri et al 2002; Copel et al 2007; Nagata et al 2007). 
We did not perform any CT colonography. The diagnosis in 
cases without obstruction (15 cases) was made on colonoscopy 
and barium enema, in the remainder of cases was made either 
by rectoscopy, or sigmoidoscopy or intraoperatively because 
of bowel obstruction. It is known that colonoscopy represents 
the golden standard for the diagnosis of colorectal malignant 
tumours, because if it is done for the entire colon may reveal any 
malignant or benign neoplasm, allowing also to perform biopsies 
which can reveal the type of the tumor. A CT-colonography may 
be less invasive, better tolerated by cannot allow the performing 
the biopsies. For the diagnosis it is very useful especially in cases 
with obstructing tumours, being impossible for the colonoscope 
to pass through the stenosis into the more proximal segments 
of the large bowel. 
It was observed that the patients with a first tumour located 
within the proximal colon had a twofold increased the risk for 
developing metachronous colorectal cancer (Gervaz et al 2005). 
In our series we had also metachronous malignant lesions, some 
of them synchronously appeared when they were multiple. Also, 
considering from the point of view of synchronous cancers, 
there were patients who developed earlier another malignant 
colorectal tumour. 
Our series consists of a small number of patients with synchronous 
colorectal malignant tumours collected in more than 7 years from 
a larger number of patients having a colorectal cancer. Usually, 
colorectal cancer presents alone, as a singular cancer, but in certain 
conditions (FAP, colorectal polyposis, Lynch syndromes) it may 
appear multiple cancers with a large bowel localization. We had 
only one patient diagnosed with familial adenomatous polyposis 
and other two patients with colorectal malignant polyposis. In 
this series we had no patient diagnosed with multiple colorectal 
cancers, part of a hereditary non-polyposis colorectal syndrome. 
In literature it was sustained that the survival may be better 
for patients with multiple colorectal tumours (Nikoloudis et al 
2004) because of an appropriate control of patients. Women have 
better survival rate than men, and in some series the synchronous 
cancer is located in the right colon (Derwinger and Gustavsson 
2011). We have diagnosed metachronous colorectal cancer 
because of the surveillance of a previous cancer in 4 patients. In 
2 patients the synchronous cancer not diagnosed preoperatively, 
but it was discovered through an appropriate exploration of the 
peritoneal cavity. In another case, the synchronous cancer was 
diagnosed only after a small period of time because of bowel 
obstruction. This has to underline the importance of a proper 
exploration of peritoneal cavity, especially in patients without 
an entire bowel exploration through colonoscopy or CT scan 
performed preoperatively, usually because of bowel obstruction. 
The colonoscopy of the entire large bowel and rectum has to 
be done in order to avoid the remaining in place of a possible 
tumour (Grodos and Haot 1987), either benign or especially 
malignant synchronous lesion. Also, colonoscopy has to be 
made periodically for the residual colon all the rest of patient life Chirilă et al 2012
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(Evers et al 1988) because of metachronous malignant lesions. 
Many patients had also associated diseases, some of them in 
advanced stages. The patient lost within 30 days from surgical 
intervention died because of a stroke, being diagnosed with 
severe heart disease, atherosclerosis, and arterial hypertension. 
Our death rate was due to a stage IV of cancer disease. Also, we 
still have patients diagnosed with liver metastases which are alive 
2 or 3 years after the colorectal surgery. The patient diagnosed 
before surgery with liver cirrhosis is still alive.
It is interesting that even if the patients were not diagnosed 
with FAP, many of them presented a lot of polyps from which 
many cancers developed, some of them in same time and some 
after a period. These patients suffered iterative operations in 
time, usually not many years after, this giving the advice of 
performing larger operations and an appropriate surveillance. In 
cases where a total colonoscopy is impossible to make because 
of an obstruction and presentation in emergency, we need to 
perform the entire colonoscopy after surgery because of possible 
synchronous malignant lesions which cannot be intraoperative 
discovered by manual palpation. It was said that colonoscopy 
combined with intraoperative palpation of the entire large 
bowel are recommended for an early detection of synchronous 
malignant tumours (Chen et al 2000). A more aggressive 
surgical approach means performing a total colectomy with an 
ileo-rectal anastomosis, and, where polyps or other lesions are 
present in the rectum, we could performe a rectocolectomy or 
even a proctorectocolectomy with ileostomy.
Conclusions
Whenever we have a diagnosis of colorectal cancer we have to 
look for a possible synchronous neoplasm, especially malignant 
lesions. In order to do this it is necessary to perform an appropriate 
exploration, clinically and endoscopically. If an entire colonoscopy 
cannot be done preoperatively, we have an alternative with CT 
colonography. Also, the intraoperatively exploration of the 
peritoneal cavity is very important, because it may reveal other 
synchronous lesions, either benign or malignant, in colorectum 
or in another place. The clinical surveillance with periodically 
endoscopy may also diagnose in an useful therapeutic stage a 
metachronous colorectal malignant lesion. Also, we have to 
keep in mind that a patent already diagnosed with a colorectal 
cancer may develop another malignant lesion somewhere else 
in his/her body.
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